Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-01-03 17:45 |
Déclaration du nombre total de droits de vote et du nombre d’actions composant …
|
French | PDF • 225.6 KB | ||
| 2021-12-14 17:45 |
Amoeba : mise à jour du calendrier des dossiers règlementaires
|
French | PDF • 272.3 KB | ||
| 2021-12-14 17:45 |
AMOEBA: update of the regulatory application calendar
|
English | PDF • 258.0 KB | ||
| 2021-12-06 17:45 |
Déclaration du nombre total de droits de vote et du nombre d’actions composant …
|
French | PDF • 225.6 KB | ||
| 2021-11-15 17:45 |
Amoeba : L’autorité Maltaise annonce à Amoéba une conclusion d’évaluation du do…
|
French | PDF • 254.5 KB | ||
| 2021-11-15 17:45 |
AMOEBA: The Maltese authority announces to Amoeba a conclusion of the biocidal …
|
English | PDF • 216.9 KB | ||
| 2021-11-02 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 225.6 KB | ||
| 2021-10-20 14:56 |
Amoeba : publication d’un nouvel article dans le journal scientifique « Pathoge…
|
French | PDF • 212.9 KB | ||
| 2021-10-20 14:56 |
AMOEBA: publication of a new paper in the scientific journal « Pathogens »
|
English | PDF • 208.2 KB | ||
| 2021-10-07 17:45 |
Amoeba annonce l’émission de la troisième tranche de 60 obligations convertible…
|
French | PDF • 376.6 KB | ||
| 2021-10-07 17:45 |
AMOEBA announces the issuance of the third tranche of 60 bonds convertible into…
|
English | PDF • 292.0 KB | ||
| 2021-10-04 18:00 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 225.6 KB | ||
| 2021-10-04 17:45 |
AMOEBA: Availability of the Half Year Financial Report as of June 30, 2021
|
English | PDF • 237.7 KB | ||
| 2021-10-04 17:45 |
AMOEBA : Rapport Financier semestriel AU 30 JUIN 2021
|
French | PDF • 1.0 MB | ||
| 2021-09-30 17:45 |
Amoéba annonce ses résultats semestriels 2021 et poursuit le développement de s…
|
French | PDF • 334.3 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
